Barclays PLC (CGCT) reports 4.52% stake in Cartesian Growth Corp I

Rhea-AI Filing Summary

Barclays PLC filed an amended Schedule 13G reporting beneficial ownership of 4.52% of Cartesian Growth Corp I Class A common stock as of 12/31/2025. Barclays reports sole voting and dispositive power over these shares, with no shared authority.

The filing states the position is held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Cartesian Growth Corp I. Subsidiaries identified in connection with the holdings include Barclays Bank PLC and Barclays Capital Inc.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

CARTESIAN GROWTH CORP I-CL A

(Name of Issuer)

COMMON-STOCK

(Title of Class of Securities)

G19307100

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G19307100

1

Names of Reporting Persons

Barclays PLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,247,930.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,247,930.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,248,011.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.52 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CARTESIAN GROWTH CORP I-CL A
(b)	Address of issuer's principal executive offices: 505 Fifth Avenue
Item 2.
(a)	Name of person filing: Barclays PLC
(b)	Address or principal business office or, if none, residence: 1 Churchill Place, London - E14 5HP
(c)	Citizenship: X0
(d)	Title of class of securities: COMMON-STOCK
(e)	CUSIP No.: G19307100
Item 4.	Ownership
(a)	Amount beneficially owned: 1247930
(b)	Percent of class: 4.52 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1248011
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1248011
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Barclays Bank PLC, Barclays Capital Inc
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Barclays PLC

Signature:	Ramya Rao
Name/Title:	Director
Date:	02/11/2026

FAQ

What ownership stake does Barclays PLC report in Cartesian Growth Corp I (CGCT)?

Barclays PLC reports beneficial ownership of 4.52% of Cartesian Growth Corp I Class A common stock. This percentage reflects its position as of December 31, 2025, with Barclays indicating sole voting and dispositive power over the reported shares.

Is Barclays PLC seeking to influence control of Cartesian Growth Corp I (CGCT)?

Barclays PLC states the securities were acquired and are held in the ordinary course of business. The filing specifies they were not acquired and are not held for the purpose or effect of changing or influencing control of Cartesian Growth Corp I.

What type of filing did Barclays PLC submit for Cartesian Growth Corp I (CGCT)?

Barclays PLC submitted an amended Schedule 13G, a beneficial ownership report for institutional investors. The amendment reflects its position in Cartesian Growth Corp I Class A common stock as of December 31, 2025, showing a 4.52% stake.

Which Barclays entities are associated with the Cartesian Growth Corp I (CGCT) holdings?

The filing identifies Barclays Bank PLC and Barclays Capital Inc as relevant subsidiaries. These entities are listed in connection with the securities reported by Barclays PLC, which serves as the parent holding company on the Schedule 13G/A.

Does Barclays PLC have sole or shared voting power over its CGCT shares?

Barclays PLC reports sole power to vote and dispose of the Cartesian Growth Corp I Class A shares included in the filing. The Schedule 13G/A indicates there is no shared voting or dispositive power over these securities.

Why does Barclays PLC note ownership of 5 percent or less in CGCT?

The Schedule 13G/A includes an Item 5 statement that Barclays PLC holds 5 percent or less of the class. This aligns with the reported 4.52% beneficial ownership of Cartesian Growth Corp I Class A common stock as of December 31, 2025.